Michael Parini, EVP, CL&AO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,100 shares at $222.67 ($1.8M) on 2020-01-06, disclosed to the SEC on 2020-01-08.
Open-market sale of $1.8M VRTX by EVP, CL&AO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $218.93 | 400 | $88K | 4.9% |
| 2 | $220.69 | 461 | $102K | 5.7% |
| 3 | $220.69 | 461 | $102K | 5.7% |
| 4 | $221.49 | 1,599 | $354K | 19.7% |
| 5 | $221.49 | 1,599 | $354K | 19.7% |
| 6 | $222.67 | 398 |
| $89K |
| 4.9% |
| 7 | $222.67 | 398 | $89K | 4.9% |
| 8 | $223.60 | 1,063 | $238K | 13.2% |
| 9 | $223.60 | 1,063 | $238K | 13.2% |
| 10 | $224.11 | 329 | $74K | 4.1% |
| 11 | $224.11 | 329 | $74K | 4.1% |
| Total | $222.16 avg | 8,100 | $1.8M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-16 | $1.7M | — | Filing → |
| VRTX | SELL | 2021-02-09 | $415K | — | Filing → |
| VRTX | SELL | 2021-02-05 | $87K | — | Filing → |